drugset / Trial / NCT03102021
The Effect of Human Recombinant Erythropoietin in Acute Renal Failure
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if the use of erythropoietin when used in high dose during acute kidney injury can decrease the number of days of kidney injury.
Timeline
- Start
- 2006-03
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | epoetin alfa | Protein / enzyme biologic | 500 iu/kg | — |